Navigation Links
Mercator MedSystems Appoints Neil Desai, Ph.D., to Board of Directors
Date:2/14/2011

SAN LEANDRO, Calif., Feb. 14, 2011 /PRNewswire/ -- Mercator MedSystems, Inc., a privately held medical technology company focused on treating drug-resistant hypertension, announced today that Neil P. Desai, Ph.D. was elected to its Board of Directors. Dr. Desai has an extensive background in drug-delivery and global development and holds over 100 patents in the field. Prior to the acquisition of Abraxis Bioscience, Inc. (ABI), by Celgene Corporation in late 2010, he was Senior Vice-President of Global Research and Development for ABI where he was responsible for the development of ABI's proprietary product pipeline and intellectual property portfolio. He is presently Vice-President of Strategic Platforms at Celgene Corporation.

"Dr. Desai's extensive experience in drug development, global clinical research, and commercialization in an entrepreneurial environment is a perfect addition to Mercator's Board as we move to the next development stage of our unique approach to treating drug-resistant hypertension," said Thomas M. Loarie, Executive Chairman of Mercator MedSystems, Inc. Loarie also noted that this came at an ideal time with investor and strategic interest growing in hypertension treatments following the recent acquisition of Ardian, Inc., by Medtronic, Inc.

"I have been working with Mercator for over three years on collaborations using products developed by Abraxis so I have had a front row seat observing the development of their proprietary site-specific drug delivery platform," said Dr. Neil Desai. He added, "It's an exciting time in the evolution of Mercator and I am delighted to become a contributor."

Last year, pre-clinical data were presented on Mercator's therapeutic approach to drug-resistant hypertension and clinical data were presented on Athersys' use of Mercator's technology to deliver stem cells post-myocardial infarction at the 2010 Transcatheter Cardiovascular Therapeutics Conference in Washington, D.C.

About Mercator MedSystems, Inc.

Mercator MedSystems, Inc., based in San Leandro, Calif., is a privately held medical technology company focused on commercializing catheter-guided, microfluid infusion systems for site-specific delivery of therapeutic agents for applications in hypertension, cardiovascular disease, oncology and regenerative medicine.


'/>"/>
SOURCE Mercator MedSystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Relievant Medsystems Announces Completion of $20 Million Financing
2. Simcere Pharmaceutical Group Appoints Industry Veteran Mr. Hong Zhao as Executive Vice President of Sales and Marketing
3. Plato BioPharma, Inc Appoints New Board Member
4. Cayenne Medical, Inc. Appoints David B. Springer President & CEO
5. SYNARC Appoints Ciaran Cooper as Vice President, Business Development
6. Onyx Pharmaceuticals Appoints Bill Ringo to Board of Directors
7. Unilife Appoints Dr. Ramin Mojdeh as Chief Operating Officer
8. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
9. AssureRx Appoints Senior Executives in Key Roles to Drive Company Growth
10. Hologic Appoints Mark D. Myslinski as Senior Vice President and General Manager of Diagnostics
11. Sysmex America Appoints Vice President of Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... 18, 2017 Cogentix Medical, Inc. (NASDAQ: CGNT), ... Urology, Uro/Gyn and Gynecology markets with innovative and proprietary ... ended March 31, 2017 after the market close on ... will host a conference call and webcast to discuss ... 2, 2017 at 4:30 p.m. Eastern Time (3:30 p.m. ...
(Date:4/18/2017)... , April 18, 2017 Research and ... Market 2017-2021" report to their offering. ... The global arthroscopy devices market to grow at a ... report, Global Arthroscopy Devices Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/18/2017)... and BLOOMINGTON, Minn. , April ... IMMY ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, ... Lens"), today announced the signing of a three-year ... Lens will deploy a dedicated sales team to ... the U.S., primarily focused in 13 states in ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like ... in a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria ... now offers this revolutionary treatment with or without a referral. , Wilckodontics ...
(Date:4/25/2017)... ... , ... Back Pain Centers of America (BPC), which connects people ... their area, announces the launch of a new and proprietary customer relationship management (CRM) ... reputable physicians to help them with back or neck pain and helps to match ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® , a ... UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event ... the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair ...
(Date:4/24/2017)... FLORIDA (PRWEB) , ... April 24, 2017 , ... ... telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, ... LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet ...
Breaking Medicine News(10 mins):